CELLULAR INTERACTIONS RESPONSIBLE FOR DEVELOPMENT, MAINTENANCE, AND STRENGTH OF THE SKELETON
With
Prof Natalie A Sims, PhD.
Deputy Director, St. Vincent’s Institute,
Melbourne, Australia
RESEARCHER PROFILE
Filmed in Melbourne, Australia | May 2025
Professor Sims directs the Bone Cell Biology and Disease Unit at St. Vincent’s Institute of Medical Research and is a Professorial Fellow at The University of Melbourne and Australian Catholic University.
She leads a team who studies the cellular interactions responsible for development, maintenance, and strength of the skeleton. She completed her PhD at the University of Adelaide, followed by postdoctoral work at the Garvan Institute in Sydney then at Yale School of Medicine, in New Haven, Connecticut, where she studied the role of the estrogen receptor in regulating bone structure.
She returned to Australia in 2001 to set up a laboratory at St. Vincent’s Hospital and SVI. Her laboratory studies the cellular interactions responsible for development, maintenance, and strength of the skeleton, including the IL-6 family of cytokines, using genetically altered mouse models, in vitro system and human specimens. She has published more than 140 peer reviewed original research articles, 48 peer reviewed review articles and commentaries, and 20 published chapters; H index of 64 (Scopus); more than 13,500 career citations.
Her work has been recognised by awards from her colleagues internationally, including the International Bone and Mineral Society Herbert A Fleisch Award (2013) and the American Society of Bone and Mineral Research (ASBMR) Fuller Albright Award (2010) and Paula Stern Award (2020).
She is a Deputy Editor of the Journal of Bone and Mineral Research and serves on the Editorial Board of the Journal of Biological Chemistry. She has served as President of the Australia and New Zealand Bone and Mineral Society and is currently Executive Secretary of the International Federation of Musculoskeletal Research Societies.
Source: Supplied
-
Therapy to prevent hepatocellular carcinoma in people with liver cirrhosis
Professor John Olynyk is a Gastroenterologist & Hepatologist with over 30 years’ experience, primarily at The Fiona Stanley & Fremantle Hospital Group. He planned the Gastroenterology and Hepatology Service for the Fiona Stanley Hospital and was Head Department from 2010 until 2020.
Professor John Olynyk was appointed as Associate Dean and Head of the Medical Discipline at Curtin University in 2023 until 2025 and is now Associate Director, Clinical Engagement, Curtin Medical Research Institute, Curtin University.
-
Superslayer taking on antibiotic-resistant bacteria
Dr Katharina Richter is a visionary leader in MedTech, acclaimed for innovation and gender diversity. With over 40 awards to her name, including MIT Innovator Under 35 Asia-Pacific, and Prime Minister’s Prize for New Innovator finalist, she has shattered barriers as an entrepreneur, scientist, and ‘superbug slayer.’ Katharina’s groundbreaking work in combating antibiotic-resistant bacteria has resulted in 6 innovative treatments, 3 of which are patented, offering hope against deadly infections.
-
Renal care & data linkage of Tasmanian kidney disease cases
Professor Matthew Jose is a Renal Physician & Head of the Renal Unit at the Royal Hobart Hospital, and Professor of Medicine for the University of Tasmania.
Winner of the 2021 Rural Science Award from the Australia and New Zealand Society of Nephrology, he has worked in regional, rural and remote Australian locations for nearly 20 years as a Renal Physician, including the Northern Territory.
